AZ2-13269-04774
2 vaccinations
1 coded response
18 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 559 / MN
- Registered
- 2021-06-05
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-05-28
Dose 1 — Moderna
-
2021-06-05
Registered in v-safe
- 2021-06-05
- 2021-06-11
- 2021-06-18
- 2021-06-25
-
2021-07-01
Dose 2 — Moderna
-
2021-07-02
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body achesAdult check-in
- 2021-07-03
-
2021-07-05
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Itching · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-07-06
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Itching · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-07-07
- 2021-07-08
- 2021-07-15
- 2021-07-22
- 2021-07-29
- 2021-08-05
- 2021-08-12
- 2021-09-30
-
2021-12-30
Survey response — 6 months, dose 2MedDRA: Oropharyngeal pain, Rhinorrhoea — Feeling: Good · Be unable to work or attend schoolFree text: Sore throat and running noseMedDRA releases: 2024-11 · check-in free text available
- 2022-07-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-28 | Moderna | |
| 2 | 2021-07-01 | Moderna | No |
Free text
Release 10 — 6 months, dose 2
Symptoms: Sore throat and running nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release